IRhythm Technologies Ownership
| IRTC Stock | USD 108.33 1.34 1.25% |
Shares in Circulation | First Issued 2015-09-30 | Previous Quarter 31.1 M | Current Value 31.3 M | Avarage Shares Outstanding 25.7 M | Quarterly Volatility 4.9 M |
IRhythm |
IRhythm Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 4.91. iRhythm Technologies had not issued any dividends in recent years. iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram monitoring products for patients at risk for arrhythmias in the United States. The company was incorporated in 2006 and is headquartered in San Francisco, California. Irhythm Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1700 people. To learn more about iRhythm Technologies call Quentin Blackford at 415 632 5700 or check out https://www.irhythmtech.com.Besides selling stocks to institutional investors, IRhythm Technologies also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different IRhythm Technologies' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align IRhythm Technologies' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
IRhythm Technologies Quarterly Liabilities And Stockholders Equity |
|
IRhythm Technologies Insider Trades History
Less than 1% of iRhythm Technologies are currently held by insiders. Unlike IRhythm Technologies' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against IRhythm Technologies' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of IRhythm Technologies' insider trades
IRhythm Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as IRhythm Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading iRhythm Technologies backward and forwards among themselves. IRhythm Technologies' institutional investor refers to the entity that pools money to purchase IRhythm Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 733.3 K | Bnp Paribas Investment Partners Sa | 2024-09-30 | 707.2 K | Champlain Investment Partners, Llc | 2024-09-30 | 667.1 K | Blair William & Co | 2024-09-30 | 644.4 K | Westfield Capital Management Company, L.p. | 2024-09-30 | 528.3 K | Allspring Global Investments Holdings, Llc | 2024-09-30 | 520 K | Slate Path Capital Lp | 2024-09-30 | 510.5 K | Bank Of America Corp | 2024-09-30 | 411.6 K | Stephens Inv Mgmt Group Llc | 2024-09-30 | 400.3 K | Vanguard Group Inc | 2024-09-30 | 3.1 M | Artisan Partners Limited Partnership | 2024-09-30 | 2.8 M |
iRhythm Technologies Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRhythm Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRhythm Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IRhythm Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
IRhythm Technologies Outstanding Bonds
IRhythm Technologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. iRhythm Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IRhythm bonds can be classified according to their maturity, which is the date when iRhythm Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| International Game Technology Corp BondUS460599AD57 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
IRhythm Technologies Corporate Filings
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 8th of January 2025 Other Reports | ViewVerify | |
F4 | 27th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 12th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.91) | Revenue Per Share | Quarterly Revenue Growth 0.184 | Return On Assets | Return On Equity |
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.